<img alt="" src="https://secure.perk0mean.com/184504.png" style="display:none;">
Skip to content
Request a demo

Using Flexible Cohort Management to Enable Creativity in Oncology Designs

Download this position paper to learn:

  • How flexible cohort management can enable complex oncology designs
  • 5 key capabilities of cohort management necessary to support creativity
  • Importance of both control and flexibility in cohort management
  • Benefits of an integrated supply forecasting engine to reduce overage



Download the white paper

open-quoteThe FDA is making a considerable effort to drive efficiencies in clinical trial research, especially when it comes to oncology studies. In 2017 alone, there were 46 new oncology drugs approved by the FDA, including 18 Fast Track Designated products and 17 Break-Through therapies.close-quote